Skip to main content

. 1985 Sep 7;291(6496):637. doi: 10.1136/bmj.291.6496.637

Reversal of liver damage due to long term methyltestosterone and safety of non-17 alpha-alkylated androgens.

C P Lowdell, I M Murray-Lyon

PMCID: PMC1417521 PMID: 3928062

637

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Ishak K. G. Hepatic lesions caused by anabolic and contraceptive steroids. Semin Liver Dis. 1981 May;1(2):116–128. doi: 10.1055/s-2008-1040724. [DOI] [PubMed] [Google Scholar]
Nusinovici V. Stéroïdes anabolisants et cholestase. Med Chir Dig. 1974;3(3):167–171. [PubMed] [Google Scholar]
Paradinas F. J., Bull T. B., Westaby D., Murray-Lyon I. M. Hyperplasia and prolapse of hepatocytes into hepatic veins during longterm methyltestosterone therapy: possible relationships of these changes to the developement of peliosis hepatis and liver tumours. Histopathology. 1977 Jul;1(4):225–246. doi: 10.1111/j.1365-2559.1977.tb01663.x. [DOI] [PubMed] [Google Scholar]
Turani H., Levi J., Zevin D., Kessler E. Hepatic lesions in patients on anabolic androgenic therapy. Isr J Med Sci. 1983 Apr;19(4):332–337. [PubMed] [Google Scholar]

ACTIONS

RESOURCES